K8凯发(中国)天生赢家·一触即发
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Jun 29, 2021
Poll results of the annual general meeting held on june 29, 2021
Read More
Jun 04, 2021
Monthly Return
Read More
May 07, 2021
(Revised) Monthly Return
Read More
May 06, 2021
Grant of Share Options
Read More
May 06, 2021
Monthly Return
Read More
Apr 23, 2021
Clarification Announcement Regarding The Circular
Read More
Apr 23, 2021
Voluntary Announcement—New Drug Application for Dorzagliatin Accepted in China by the National Medical Products Administration
Read More
Apr 22, 2021
Notice of Annual General Meeting
Read More
Apr 22, 2021
(I) Proposed Re-election of Retiring Directors; (II) Proposed Granting of General Mandates to Repurchase Shares and to Issue Shares; (III) Proposed Re-appointment of Auditor; (IV) Notice of Annual General Meeting
Read More
Apr 22, 2021
Form of Proxy for the Annual General Meeting to be Held On Tuesday, June 29
Read More
Apr 08, 2021
Monthly Return
Read More
Mar 22, 2021
Grant of Share Options
Read More
<<
<
5
6
7
8
9
10
11
12
13
14
15
>
>>
上一页
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Subscribe Email
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: (沪)-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x
友情链接:
南宫28NG相信品牌力量
凯发k8天生赢家一触即发
凯发k8天生赢家一触即发
球盟会官网入口
k1体育